Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)

SIMPLE SUMMARY: In the context of a growing variety in treatment strategies for patients with cancer, especially approaches based on antiangiogenetic pathways, we aimed to identify a useful biomarker for patients with head and neck squamous cell carcinoma (HNSCC). Our experimental results detected v...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemert, Julia, Wald, Theresa, Kolb, Marlen, Pettinella, Isolde, Böhm, Ulrike, Pirlich, Markus, Wiegand, Susanne, Dietz, Andreas, Wichmann, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345208/
https://www.ncbi.nlm.nih.gov/pubmed/34359680
http://dx.doi.org/10.3390/cancers13153781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345208/
https://www.ncbi.nlm.nih.gov/pubmed/34359680
http://dx.doi.org/10.3390/cancers13153781

Ejemplares similares